NZ205238A - Synergistic mixtures as anthelmintic - Google Patents
Synergistic mixtures as anthelminticInfo
- Publication number
- NZ205238A NZ205238A NZ205238A NZ20523883A NZ205238A NZ 205238 A NZ205238 A NZ 205238A NZ 205238 A NZ205238 A NZ 205238A NZ 20523883 A NZ20523883 A NZ 20523883A NZ 205238 A NZ205238 A NZ 205238A
- Authority
- NZ
- New Zealand
- Prior art keywords
- active
- formula
- compound
- substance
- substance combination
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 24
- 230000002195 synergetic effect Effects 0.000 title claims description 6
- 230000000507 anthelmentic effect Effects 0.000 title description 10
- 239000013543 active substance Substances 0.000 claims description 39
- 241001465754 Metazoa Species 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 27
- 241000242711 Fasciola hepatica Species 0.000 claims description 12
- 244000000013 helminth Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- 239000000969 carrier Substances 0.000 claims description 6
- 241000869417 Trematodes Species 0.000 claims description 5
- 230000003071 parasitic effect Effects 0.000 claims description 5
- 230000037396 body weight Effects 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000002270 dispersing agent Substances 0.000 claims description 3
- 208000006275 fascioliasis Diseases 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 241001125671 Eretmochelys imbricata Species 0.000 claims 1
- 241001494479 Pecora Species 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 241000244206 Nematoda Species 0.000 description 5
- 239000008187 granular material Substances 0.000 description 4
- 208000015336 Helminthic disease Diseases 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229940124339 anthelmintic agent Drugs 0.000 description 3
- 239000000921 anthelmintic agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010061217 Infestation Diseases 0.000 description 2
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000242541 Trematoda Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 229960001614 levamisole Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 2
- 239000004563 wettable powder Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSAPYRIVHFAQGR-UHFFFAOYSA-N 1-sulfanylbenzimidazole Chemical compound C1=CC=C2N(S)C=NC2=C1 KSAPYRIVHFAQGR-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- QOUSCKKLBRWNSE-UHFFFAOYSA-N 2-octadecyl-1h-benzimidazole Chemical class C1=CC=C2NC(CCCCCCCCCCCCCCCCCC)=NC2=C1 QOUSCKKLBRWNSE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000204939 Fasciola gigantica Species 0.000 description 1
- 241000243974 Haemonchus contortus Species 0.000 description 1
- 108010034145 Helminth Proteins Proteins 0.000 description 1
- 208000006968 Helminthiasis Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000243796 Trichostrongylus colubriformis Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- GRTOGORTSDXSFK-XJTZBENFSA-N ajmalicine Chemical compound C1=CC=C2C(CCN3C[C@@H]4[C@H](C)OC=C([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 GRTOGORTSDXSFK-XJTZBENFSA-N 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000007931 coated granule Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000004491 dispersible concentrate Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000479 mixture part Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000004767 rumen Anatomy 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000723 toxicological property Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
New Zealand Paient Spedficaiion for Paient Number £05238
205238
Priority Date(s): lO.rf?'.
Publication Date:
2 4 JAN 1986
P.O. Journal. No:
NO DRAWINGS
Patents Form No. 5
NEW ZEALAND PATENTS ACT 1953 COMPLETE SPECIFICATION "ANTHELMINTICS"
WE, CIBA-GEIGY AG, a Swiss Corporation of Klybeckstrasse 141, 4002 Basle, Switzerland,
hereby declare the invention, for which we pray that a patent may be granted to us,and the method by which it is to be performed, to be particularly described in and by the following statement
(follcv/ad I v -?>»<? 1 A ^
205238
- 1 P>-
Case 5-14050/=
ANTHELMINTICS
The present invention relates to novel synergistic anthelmintic compositions containing as active component 5 an active-substance combination, and to the use of these compositions for controlling helminths, particularly trematodes and nematodes, in domestic animals and in productive animals.
compositions according to the invention are based have an unexpected synergistic activity exceeding in a very advantageous manner the additive effect of the individual active substances forming the combination. The active-substance combinations according to the invention comprise 15 the following individual active substances:
a compound of the formula I
The active-substance combinations on which the n
(I)
ci \i wherein n is zero or 1,
and the compound of the formula II
205238
I—I—I •
including the isomers thereof as well as the addition salts thereof embraced by the formula II.
The compounds described in the foregoing as active-5 substance components of the compositions according to the invention are known individually as being compounds having anthelmintic activity. Compounds of the formula I are described for example in the New Zealand Patent Specification No. 186,936, and the compound of the formula II in 10 the U.S. Patent Specifications Nos. 3,274,209, 3,565,907 and 3,579,530, in the GB Patent Specification No. 1,175,270, in Tetrahedron Letters 1967, 1467, and in Am. Journ. Vet. Res. J32, 545 (1971).
The combination of different chemical compounds to 15 produce a synergistic intensification of activity for controlling pests is gaining to an increasing extent in importance because of the possibility the combination offers for effectively counteracting the ever more frequent appearance of resistance of parasites to individual 20 compounds. Consequently, the normally necessitated increase in the amounts of active substance used to overcome this build-up of resistance of the parasites can largely be avoided. The resulting saving in the amounts of active substance applied has both economic and, by virtue of a 25 lessening of environmental contamination, significant ecological advantages. In the administration of anthelmintics to productive animals, this can mean a continuance of the applied dose that can be tolerated or even a , - reduction in the dose applied, with which is simultaneously
205238
associated a lowering of the level of intoxication of the treated animals, with the result that their effective output during the treatment is not impaired.
Helminthic diseases among domestic animals and 5 productive animals are widespread as is well known, and these diseases lead to a reduction in the growth and in the output of the affected animals, and in many cases even result in their death. A particularly dangerous helminthic disease is Fasciolose, which is caused by parasitic liver 10 flukes (for example Fasciola hepatica and Fasciola gigantica), and which occurs especially in ruminants, such as sheep and cattle. The losses attributable to this helminthic disease can assume considerable proportions, particularly when this disease occurs in epidemic form in 15 herds of cattle. The control and prevention of Fasciolose are therefore considered a matter of urgency in order that such, above all economically grave, losses in animal production may be avoided. In spite of the numerous known preparations in the field covering the control of 20 helminths, it has hitherto not been possible to develop active substances which, in addition to having good general anthelminthic properties, exhibit a satisfactory action against adult and juvenile Fasciola genera in sheep and cattle, while simultaneously having low toxicity.
It has now been found that the active-substance combinations which are contained in the compositions according to the invention, and which comprise a compound of the formula I and the compound of the formula II,
display a high level of anthelminthic activity, having not 30 only a wide spectrum of activity against nematodes and trematodes, hut also a very strongly marked action against Fasciola hepatica in sheep. To be emphasised as being particularly advantageous is the fact that the active-
205238
substance combinations on which the compositions according to the invention are based have, even in very small doses, a total action against liver flukes in sheep, so that side-effects, which could result in an impairment of the development and of the effective output of the treated animals during the period of treatment, are avoided by virtue of small doses. The action of the active-substance combinations according to the invention against Fasciola hepatica is significantly greater than the additive action of the individual compounds forming the combinations. Furthermore, the broad spectrum of activity induced by the composition specific to the invention is of particular advantage. The animals affected by helminthiasis can thus be treated by a single administration of an active-substance combination according to the invention simultaneously both for nematodes and for trematodes of all development stages. Included also are in particular those nematode strains which show resistance to thiabendazole (2-[4-thiazolyl]-benzimidazole),and in some cases also to other benzimidazole derivatives.
The following combination is to be regarded as being preferred:
A) 5-chloro-6-(2',31-dichlorophenoxy)-2-methylthio-benzimidazole with
B) L-(-)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole
("Levamisol").
The applicable weight ratios of compounds of the formula I to the compound of the formula II for the active-substance combinations according to the present invention are within the range of 1:5 to 5:1. The combination ratio of 1:5 to 1:1 is particularly favourable for bringing into effect the synergistic action. The
2052
amount to be used of the compound of the formula I is preferably below 6 ir.g of active substance (AS)/kg of body weight.
The anthelmintic action of the inventive active-5 substance combinations of compounds of the formula I with the compound of the formula II is demonstrated by the following test.
Test on sheep infested with Fasciola hepatica and nematodes
Sheep are artificially infested with metacercaria of Fasciola hepatica. For this purpose, the metacercaria are injected, in a 0.47o aqueous suspension of carboxy-methyl cellulose, directly into the rumen of the test animals. The sheep are simultaneously orally infested 15 each with 10,000 and 5,000 infectious larvae (L 3) of benzimidazole-resistant Trichostrongylus colubriformis and Haemonchus contortus, respectively. The animals are divided for medication into equally large groups and one control group. The active-substance combinations, 20 in which the proportion of active substance of the formula I is 2-5 mg/kg and the proportion of active substance of the formula II is 3-7 mg/kg, are subsequently administered to the test animals. The sheep are kept during the test under normal conditions in paddock boxes. 25 In order to test the action of the individual active-
substance combinations, a count is made, using a standard technique, at specific intervals of time after infestation and medication, of the helminth eggs excreted with the faeces. The test animals are subsequently killed and the 30 number of adult helminths present is determined.
The results provided by the medicated groups and the control group are compared for the purpose of making an evaluation.
205238
Results:
The active-substance combinations on which the compositions according to the invention are based are 95-100% effective against Fasciola hepatica. The action 5 of these combinations in comparable or even lower doses is therefore significantly above the additive action of the individual compounds forming the combinations.
After administration of the therapeutically effective doses of the active-substance combinations, clinical 10 tests reveal no toxicity symptoms in the test animals; and these animals have moreover a healthy appearance.
2052 3
Example: Comparative test: results Indication: Fasciola hepatica
Number of test animals (sheep): 19
Sheep
Substance or mixture of substances (dose mg/kg)
EPG
Adult helminths
No.
12th week* ;13 th week'"' ;■ i number mean | value reduction in % ;1 ;210 ;130 ;58 ;2 ;3 ;I (2,5) ;160 120 ;160 180 ;65 51 ;48,5 ;52,7 , ;4 ;20 ;15 ;20 ;5 ;990 ;1140 ;108 ;6 ;7 ;II (6,75) ;160 226 ;250 250 ;71 89 ;92,8 ;9,6 ;8 ;225 ;810 ;103 ;9 ;0 ;0 ;3 ;10 ;11 ;12 ;I + II (2,5 + 6,75) ;' ;170 0 0 ;210 50 30 ;43 19. 27 ;23,0 ;77,6 ' ;13 ;710 ;680 ;99 ;\) ;14 ;15 ;16 ;17 ;untreated control animals ;400 1290 580 860 ;670 1270 660 850 ;60 113 130 99 ;102,6 ;X ;18 ;570 ;410 ;110 ;/ \ ;19 ;1 ;600 ;1450 ;i 116 1 ;/ \ ;Substance I: 5-chloro-6-(21,3'-dichlorophenoxy)-2-methyl- ;thiobenzimidazole, ;Substance II: L-(-)-2,3,5,,6-tetrahydro-6-phenylimidazo-[ 2 , 1-b ] -thiazole ("Levamisol"). ;EPG: number of-eggs per gram of faeces ;* after infestation
2 0 5238
The active-substance combinations according to the invention are used to control parasitic helminths in domestic animals and productive, animalss such as cattle, sheep and goats. The combinations can be administered 5 either in single doses to the animals, or in repeated doses, the single doses being, depending on the species of animal, between 0.5 and 7.5 mg per kg of body weight. A better effect can be obtained in some cases by a protracted administration, or smaller complete doses may 10 suffice. The active substances or the mixtures containing them can also be added to the feed or be introduced into drinking troughs. The finished feed contains the active-substance combinations preferably at a concentration of 0.005 to 0.1 % by weight. The compositions can be 15 administered to the animals perorally in the form of solutions, emulsions, suspensions (drenches), powders, tablets, boluses or capsules. These preparations are prepared by the use for example of customary solid carriers, such as kaolin, talcum, bentonite, sodium chloride, calcium 20 phosphate or cottonseed meal, or by the use of liquids that do not react with the active substances, such as oils and other solvents and diluents harmless to the animal organism. Provided that the physical and toxicological properties of solutions or emulsions permit it, the active-substance 25 combinations can be also injected into the animals for example subcutaneously, or can be applied by means of the pour-on-method. Furthermore, administration of the active substances to the animals is also possible by means of licking stones (salt) or molasses blocks.
When the anthelmintic compositions are in the form of feed concentrates, the main carriers used are feed materials, such as hay, production feed, fodder grain or protein concentrates. The feed can contain, in addition to
205238
the active substances, also additives, vitamins, antibiotics, chemotherapeutical agents, or other pesticides, chiefly bacteriostatics, fungistatics, coccidlostatics; and also hormone preparations, substances having anabolic activity, or other substances promoting growth, affecting the quality of the meat of slaughter cattle, or being in some other way beneficial for the organism. They can also be combined with insecticides and acaricides, by virtue of which the action of the compositions is broadened and adapted to suit the given circumstances.
The anthelmintic compositions according to the invention are produced in a manner known per se by the intimate mixing and grinding of the active-substance combinations, comprising compounds of the formula I and the compound of the formula II, with suitable carriers, optionally with the addition of dispersing agents or solvents which are all inert to the active substances.
The anthelmintic compositions according to the invention can be used for example in the following preparations:
Solid preparations:
granulates (coated granules, impregnated granules and homogeneous granules); water-dispersible concentrates of active substance (wettable powder).
Liquid preparations:
solutions, pastes, emulsions, particularly ready-for-use suspensions (drenches).
The particle size of the carriers is advantageously up to about 0.1 mm for dusts and wettable powders, and 0.01 - 0.5 mm for granulates.
The concentration of the active-substance combinations in the solid preparations is 0.5 to 80%, and 0.5 to 50%
205238
in the liquid preparations.
To these mixtures can also be added additives stabilising the active-substance combinations, and/oi. nonionic, anionic and cationic substances, which ensure 5 for example better wettability (wetting agents) and dispersibility (dispersing agents).
Example
Water-dispersible powder mixture
parts by weight of an active-substance combination 10 of compounds of the formula I with the compound of the formula II are thoroughly mixed, in a mixer,
with
7.5 parts by weight of an absorbent carrier, for example silicic acid,
59.4 parts by weight of a carrier, for example bolus alba or kaolin,
0.5 part by weight of oleic acid,
.3 parts by weight of octylphenylpolyglycol ether, and 2.3 parts by weight of a stearyl-benzimidazole derivative
This mixture is ground in a dowelled disk mill or an air-jet mill until the particle size is 5-15 /pm. The wettable powder thus obtained gives a good suspension in water.
205238
- ].i -
Claims (9)
1. A synergistic composition for controlling parasitic helminths, which composition contains as active component an active-substance combination comprising at least one 5 compound of the formula I CI \ CK A I I • • < ^ ^ / /* ~ * N.-S -v / If Y (0>n CH. (I), 10 wherein n is zero or 1, and the compound of the formula II A A (id . .1 -vf" including the isomers thereof, as well as the addition salts thereof, embraced by the formula II, wherein the weight ratio of ccnpounds of the formula I to the compound of the formula II in the active-substance combination is 1:5 to 5:1, together with suitable carriers and/or dispersing and diluting agents.
2. A composition according to Claim 1 for controlling parasitic helminths, which contains as active component 15 an active-substance combination comprising 5-chloro-6- (2 1,3 ' -dichlorophenoxy) -2-methylthiobenziniidazole and L-(-)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]-thiazole, together with suitable carriers and/or dispersing and 20 diluting agents. ^ c.- "crisisi A 205238 - 12 -
3. A composition according to Claim 1 or 2, wherein the weight ratio of compounds of the formula I to the 5 compound of the formula II in the active-substance combination is 1:5 to 1:1.
4. A composition according to any one of Claims 1-3 for controlling trematodes.
5. A composition according to any one of Claims 1-3 for 10 controlling liver flukes (Fasciola hepatica).
6.. A method of controlling parasitic helminths, which method comprises treating the non-human host animal with an effective amount of an active-substance combination according to any one of Claims 1-3. 15
7. A method according to Claim 6 wherein the helminths are trematodes.
8. A method according to Claim 6 wherein the helminths are liver flukes (Fasciola hepatica) .
9. A method according to Claim 6, wherein the proportion 20 of the compound of the formula I in the active-substance combination is less than 6 mg of AS/kg of body weight. BALDWIN, SON & CAREY "~ATO«^EY^&R^^Pfl,CANTS Yi c \ I" 3 10CT 19855$ V /
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH486682 | 1982-08-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ205238A true NZ205238A (en) | 1986-01-24 |
Family
ID=4283918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ205238A NZ205238A (en) | 1982-08-13 | 1983-08-12 | Synergistic mixtures as anthelmintic |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0101412B1 (en) |
| JP (1) | JPS5948420A (en) |
| AU (1) | AU567299B2 (en) |
| DE (1) | DE3379497D1 (en) |
| ES (1) | ES8502610A1 (en) |
| GB (1) | GB2124904B (en) |
| NL (1) | NL930087I1 (en) |
| NZ (1) | NZ205238A (en) |
| ZA (1) | ZA835956B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4781920A (en) * | 1984-11-13 | 1988-11-01 | American Cyanamid Company | Anthelmintic paste compositions containing resinates of d1-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole |
| ES2170099T3 (en) * | 1993-05-26 | 2002-08-01 | Commw Scient Ind Res Org | ANTIPARASITARY COMPOSITIONS. |
| AU687062B2 (en) * | 1993-05-26 | 1998-02-19 | Commonwealth Scientific And Industrial Research Organisation | Controlled release antiparasitic compositions |
| DE69432985D1 (en) * | 1993-06-15 | 2003-09-04 | Australian Nat University Acto | SYNERGISTIC ANTHELMINTIC COMPOSITIONS AGAINST FASCIOLA HEPATICA AND OTHER FASCOLA SPECIES |
| CN102895180A (en) * | 2012-09-29 | 2013-01-30 | 天津必佳药业集团有限公司 | Parasitic disease resistant compound triclabendazole transdermal solution for cattle and sheep and preparation method thereof |
| CN102872013A (en) * | 2012-10-26 | 2013-01-16 | 天津必佳药业集团有限公司 | Anti-parasitic disease compound Triclabendazole granule for flocks and herds and preparation method for anti-parasitic disease compound Triclabendazole granule |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL54474A (en) * | 1977-04-12 | 1982-04-30 | Ciba Geigy Ag | Benzimidazole derivatives,their preparation and anthelmintic compositions containing them |
-
1983
- 1983-08-01 GB GB08320650A patent/GB2124904B/en not_active Expired
- 1983-08-08 EP EP83810351A patent/EP0101412B1/en not_active Expired
- 1983-08-08 DE DE8383810351T patent/DE3379497D1/en not_active Expired
- 1983-08-12 NZ NZ205238A patent/NZ205238A/en unknown
- 1983-08-12 ES ES524897A patent/ES8502610A1/en not_active Expired
- 1983-08-12 ZA ZA835956A patent/ZA835956B/en unknown
- 1983-08-12 AU AU17927/83A patent/AU567299B2/en not_active Expired
- 1983-08-12 JP JP58146769A patent/JPS5948420A/en active Granted
-
1993
- 1993-06-23 NL NL930087C patent/NL930087I1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE3379497D1 (en) | 1989-05-03 |
| GB8320650D0 (en) | 1983-09-01 |
| EP0101412A2 (en) | 1984-02-22 |
| GB2124904A (en) | 1984-02-29 |
| NL930087I1 (en) | 1993-09-16 |
| GB2124904B (en) | 1986-01-15 |
| EP0101412B1 (en) | 1989-03-29 |
| EP0101412A3 (en) | 1985-06-05 |
| AU1792783A (en) | 1984-02-16 |
| ZA835956B (en) | 1984-04-25 |
| JPS5948420A (en) | 1984-03-19 |
| JPH0347250B2 (en) | 1991-07-18 |
| ES524897A0 (en) | 1985-01-16 |
| AU567299B2 (en) | 1987-11-19 |
| ES8502610A1 (en) | 1985-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ205238A (en) | Synergistic mixtures as anthelmintic | |
| CA1200200A (en) | Anthelmintics | |
| US3558778A (en) | Methods and compositions for use in animal husbandry | |
| US3325356A (en) | Compositions and method for treating helminthiasis | |
| US3065133A (en) | Imidazoles for the control of histomoniasis | |
| CA1217430A (en) | Anthelmintics | |
| EP0125004B1 (en) | Synergistic antiparasitic compositions | |
| US3987181A (en) | Certain 2-trifluoromethylbenzimidazoles as anthelmintics | |
| US4436737A (en) | Anthelmintic compositions | |
| IE832793L (en) | Synergistic anthelmintic composition. | |
| US3469009A (en) | Benzothiazolium complexes for control of parasitic organisms in animals | |
| DE2800740A1 (en) | ANTHELMINTICA | |
| US3958008A (en) | Anthelmintic methods of use | |
| US3968209A (en) | Anthelmintic use of phosphorylated thioureas | |
| US4070476A (en) | Topical anthelmintic compositions and methods of use | |
| DE1617414A1 (en) | Wormer | |
| US2826531A (en) | Nematode-control compositions of alpha, alpha' di-chloro-p-xylene and methods of using | |
| US4042703A (en) | Method of treating and preventing coccidiosis | |
| CH540281A (en) | Veterinary anthelmintic 4-(isothiocyanophen - yl)-thiazoles | |
| US3475536A (en) | Method for the systemic control of ectoparasites with phosphorodiamidates | |
| US3457351A (en) | Anthelmintic compositions and methods employing 2 - (2' - oxazolin-2'-yl)-benzimidazoles | |
| AT367296B (en) | METHOD FOR THE CURATIVE AND PROPHYLACTIC FIGHTING OF PARASITAL HELMINTHS | |
| US3484519A (en) | Anthelmintic 2-substituted benzimidazole-metal arsenate compositions and method | |
| US3592894A (en) | Treatment of intestinal helminthiasis with tetrachlorofulvenes | |
| US3167474A (en) | Composition for combatting coccidiosis and method of using same |